STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLPT
  4. [Form 4] ClearPoint Neuro, Inc. Insider Trading Activity

ClearPoint Neuro (CLPT) CEO acquires 1,361 ESPP shares in Form 4

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

ClearPoint Neuro, Inc. CEO and President Joseph Burnett reported routine insider activity involving company common stock. He acquired 1,361 shares of common stock on June 30, 2026 as a grant/award under the company’s Employee Stock Purchase Plan (ESPP) at $11.93 per share. The ESPP purchase covered the period from January 1, 2026 through June 30, 2026, with shares bought at 85% of the lower of the fair market value on the first or last day of that period. Following this ESPP acquisition, Burnett directly owns 118,203 shares of ClearPoint Neuro common stock and indirectly has 191,388 shares held through the Joseph M. Burnett Trust dated October 20, 2022, where he serves as trustee.

Positive

  • None.

Negative

  • None.
Insider BURNETT JOSEPH
Role CEO and President
Type Security Shares Price Value
Grant/Award Common Stock 1,361 $11.93 $16K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 118,203 shares (Direct, null); Common Stock — 191,388 shares (Indirect, See Footnote)
Footnotes (1)
  1. The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2026 through June 30, 2026. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period. These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust.
ESPP shares acquired 1,361 shares Common Stock grant/award on June 30, 2026
ESPP purchase price $11.93 per share Price for 1,361 ESPP shares on June 30, 2026
Direct holdings after transaction 118,203 shares Common Stock directly owned by Joseph Burnett
Indirect holdings after transaction 191,388 shares Common Stock held via Joseph M. Burnett Trust
ESPP discount 85% of fair market value Lesser of first or last day of Jan 1–Jun 30, 2026 period
Employee Stock Purchase Plan financial
"acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP")"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
grant/award acquisition financial
"transaction_action": "grant/award acquisition""
indirectly financial
"owned directly by the Joseph M. Burnett Trust ... and indirectly by Joseph M. Burnett as trustee"
fair market value financial
"purchased at the lesser of 85% of the fair market value on either the first day or last day"
The price a willing buyer and a willing seller would agree on for an asset or security when neither is under pressure and both have access to the same information. Think of it as the market’s neutral estimate of what something is worth, like the price two neighbors would settle on for a car after comparing similar listings. Investors care because fair market value guides buying and selling decisions, tax reporting, portfolio valuation, and how accurately company assets are reflected in financial statements.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BURNETT JOSEPH
(Last)(First)(Middle)
C/O CLEARPOINT NEURO, INC.
120 S. SIERRA AVE., SUITE 100
(Street)
SOLANA BEACH CALIFORNIA 92075
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
ClearPoint Neuro, Inc. [ CLPT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
CEO and President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/30/2026A1,361A$11.93(1)118,203D
Common Stock191,388ISee Footnote(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2026 through June 30, 2026. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period.
2. These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust.
/s/ Danilo D'Alessandro, by Power of Attorney for Joseph M. Burnett07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did ClearPoint Neuro (CLPT) report for Joseph Burnett?

ClearPoint Neuro reported that CEO Joseph Burnett acquired 1,361 shares of common stock through a grant under the Employee Stock Purchase Plan. The transaction occurred on June 30, 2026 as part of the ESPP purchase period.

How many ClearPoint Neuro (CLPT) shares does Joseph Burnett hold after this Form 4?

After this filing, Joseph Burnett directly owns 118,203 ClearPoint Neuro common shares and indirectly has 191,388 shares held through the Joseph M. Burnett Trust dated October 20, 2022, where he serves as trustee.

At what price were Joseph Burnett’s ESPP shares in ClearPoint Neuro (CLPT) acquired?

The 1,361 ClearPoint Neuro shares acquired by Joseph Burnett under the ESPP were purchased at $11.93 per share. The plan provides a 15% discount to the lower of the fair market value on the first or last day of the purchase period.

What period did the ClearPoint Neuro (CLPT) ESPP purchase for Joseph Burnett cover?

The ESPP acquisition reported for Joseph Burnett covers the purchase period from January 1, 2026 through June 30, 2026. Shares were acquired at 85% of the fair market value, based on the lesser of the starting or ending date prices.

How is Joseph Burnett’s indirect ownership in ClearPoint Neuro (CLPT) structured?

Joseph Burnett’s indirect holdings consist of 191,388 ClearPoint Neuro shares owned by the Joseph M. Burnett Trust dated October 20, 2022. He is the trustee of this trust, so the Form 4 reports these shares as indirectly owned.

Is Joseph Burnett’s ClearPoint Neuro (CLPT) transaction a market purchase or a plan acquisition?

The 1,361-share acquisition is a plan-related transaction under the Employee Stock Purchase Plan, coded as a grant or award. It reflects participation in the ESPP rather than an open-market purchase or discretionary trade.